Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,911,375
-
Share change
-
-258,791
-
Total reported value
-
$55,225,760
-
Price per share
-
$28.90
-
Number of holders
-
65
-
Value change
-
-$8,606,465
-
Number of buys
-
18
-
Number of sells
-
44
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2022
As of 30 Jun 2022,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,911,375 shares.
The largest 10 holders included
Wharton Business Group, LLC, Wealthcare Advisory Partners LLC, MORGAN STANLEY, UBS Group AG, BANK OF AMERICA CORP /DE/, JANE STREET GROUP, LLC, LPL Financial LLC, ROYAL BANK OF CANADA, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Kestra Advisory Services, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.